COVID-19: TCTMD’s Daily Dispatch for November 23
Regeneron’s antibody cocktail gets an EUA, more positive vaccine data, resilient seniors, the frequency of delirium, and more.
Related Articles
MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone
It’s possible that other classes of antithrombotics may be worth adding to improve reperfusion, but that’s conjecture right now.
ZODIAC: Laying Flat Equals Better Outcomes for Stroke Thrombectomy Candidates
”Zero-degree positioning” may be one of the most important first steps in managing large vessel occlusions, study shows.
Assisted Reproductive Technology Linked to Higher Stroke Risk
The findings shouldn’t, however, discourage those who want children from pursuing ART, experts say.
Should Conduction-System Pacing Be Top Choice for CRT?
In an EHRA debate, experts grappled with how to interpret promising preliminary data while longer-term trials are ongoing.
Good Early Results for Conformable, ‘Single-Shot’ Pulsed-Field Ablation Catheter
Initial safety and efficacy findings from this first-in-human series “look really impressive,” but experts await further studies.
Should Conduction-System Pacing Be Top Choice for CRT?
In an EHRA debate, experts grappled with how to interpret promising preliminary data while longer-term trials are ongoing.
Injectable Semaglutide Shortage Forces Physicians to Pivot
As demand for the drug continues to rise, alternatives like the oral formulation and other injectable GLP-1s come into play.
Ultralow-Temperature Cryoablation Promising for Monomorphic VT
The first-in-human results represent “an encouraging first step with a novel ablation source,” one expert says.
Stroke Rates Fall Among AF Patients Not on Anticoagulation
Findings from a Finnish study don’t reveal a reason for the trend, but some speculate it could be due to better risk factor control.
EHRA, Others Update Consensus on Catheter and Surgical Ablation of AF
The hope is that this will make ablation safer and increase the number of patients considered candidates, Stylianos Tzeis says.